Holen Sie sich die Stockscreener-App
7.83
5.81%
0.43
Handel nachbörslich:
7.87
0.04
+0.51%
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
37.82%
75.80
|
55.00 | 48.85 | 50.03 | 42.99 |
| Operating Income/Loss |
37.82%
-75.80
|
-55.00 | -48.85 | -50.03 | -42.99 |
| Income/Loss From Continuing Operations Before Tax |
44.44%
-70.06
|
-48.50 | -40.56 | -42.03 | -37.34 |
| Income/Loss From Continuing Operations After Tax |
44.44%
-70.06
|
-48.50 | -40.56 | -42.03 | -37.34 |
|
Net Income/Loss
|
44.44%
-70.06
|
-48.50 | -40.56 | -42.03 | -37.34 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | -0.192 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):